North China Pharmaceutical Company.Ltd Temettü
Temettü kriter kontrolleri 0/6
North China Pharmaceutical Company.Ltd is a dividend paying company with a current yield of 0.17%.
Anahtar bilgiler
0.2%
Temettü verimi
-9.3%
Geri Alım Getirisi
| Toplam Hissedar Getirisi | -9.1% |
| Gelecekteki Temettü Verimi | n/a |
| Temettü Büyümesi | 5.4% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | CN¥0.010 |
| Ödeme oranı | 20% |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
Benign Growth For North China Pharmaceutical Company.Ltd (SHSE:600812) Underpins Its Share Price
Sep 25
North China Pharmaceutical Company.Ltd's (SHSE:600812) Profits Appear To Have Quality Issues
Aug 20The Market Doesn't Like What It Sees From North China Pharmaceutical Company.Ltd's (SHSE:600812) Revenues Yet
Apr 26Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: 600812 is not paying a notable dividend for the CN market, therefore no need to check if payments are stable.
Büyüyen Temettü: 600812 is not paying a notable dividend for the CN market, therefore no need to check if payments are increasing.
Piyasaya Karşı Temettü Getirisi
| North China Pharmaceutical Company.Ltd Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (600812) | 0.2% |
| Pazarın Alt %25'i (CN) | 0.6% |
| Pazarın En İyi %25'i (CN) | 2.2% |
| Sektör Ortalaması (Pharmaceuticals) | 1.7% |
| Analist tahmini (600812) (3 yıla kadar) | n/a |
Önemli Temettü: 600812's dividend (0.17%) isn’t notable compared to the bottom 25% of dividend payers in the CN market (0.57%).
Yüksek Temettü: 600812's dividend (0.17%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: 600812 is not paying a notable dividend for the CN market.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: 600812 is not paying a notable dividend for the CN market.